Evidence map›Paper›PMID 40386715›Full record

ArticleTranslational lung cancer research2025

Integrating radiomics and deep learning for enhanced prediction of high-grade patterns in stage IA lung adenocarcinoma.

Zhongxiao Chen, Hao Liu, Hua Sun, Cheng Xu, Bingyu Hu, Luyu Qu, William C Cho, Thivanka Witharana, Chengchu Zhu, Jianfei Shen

Abstract read
In one paragraph

Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhongxiao Chen *Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
Hao Liu *Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
Hua Sun *Department of Cardiothoracic Surgery, Taizhou Hospital, Zhejiang University School of Medicine, Taizhou, China.
Cheng XuDepartment of Pathology, Enze Hospital, Taizhou Enze Medical Center, Taizhou, China.
Bingyu HuDepartment of Radiology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
Luyu QuDepartment of Academic Affairs, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
William C ChoDepartment of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
Thivanka WitharanaDepartment of Cardiology, Royal Glamorgan Hospital, Pontyclun, UK.
Chengchu ZhuDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
Jianfei ShenDepartment of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The presence of high-grade patterns (HGPs) often has a detrimental effect on prognosis. It is helpful to make individualized clinical treatment plans when preoperative recognition of the presence of HGPs becomes possible. So, this study aimed to develop a model based on preoperative computed tomography (CT) images to predict the presence of HPGs in invasive pulmonary non-mucinous adenocarcinoma. Methods: A retrospective analysis was conducted on 403 surgically treated patients with clinical stage IA and pathologically confirmed invasive non-mucinous adenocarcinoma. There were 256 deep learning features and 1,836 handcrafted features extracted from the regions of interest (ROIs) in preoperative CT images. The optimal subset of features was screened using Results: The fusion model combining radiomics features and deep learning features using the XGBoost classifier exhibited strong predictive efficacy with the area under the curve (AUC) of 0.983, 0.862, and 0.832 in the training, validation, and test set. It means that the model can distinguish well between tumors with and without HGPs. The fusion model had better diagnostic performance when compared to the radiomics model and deep learning model. Calibration curve indicated good coherence between model prediction and the actual observation. DCA revealed the fusion model exerted the highest clinical benefit. Conclusions: The fusion model can identify the presence of HPGs in invasive lung adenocarcinoma from preoperative CT images. It assists clinicians in determining individualized treatments and monitoring strategies for patients.

Indexed as

deep learningfusion modelHigh-grade pattern (HGP)radiomics

Identifiers

PMID40386715
PMCPMC12082195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.